<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is defined by metaplastic glandular changes to the distal esophagus and is linked to an increased risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Controversy exists whether the definition should be limited to intestinal type glands with goblet cells or should be expanded to include non-goblet cell columnar epithelium </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> may be asymptomatic in a large proportion of the population but screening should be considered for those with certain clinical findings </plain></SENT>
<SENT sid="3" pm="."><plain>The diagnosis of Barrett's should be based on the combination of careful endoscopic evaluation and histologic review of the biopsy material </plain></SENT>
<SENT sid="4" pm="."><plain>Continued surveillance biopsies may be necessary in cases of indeterminate or low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Clinical follow-up of patients with high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> should be tailored to the individual patient </plain></SENT>
<SENT sid="6" pm="."><plain>Development of newer endoscopy techniques including chemoendoscopy, chromoendoscopy and use of biomarkers on frozen tissue have shown some promise of identifying patients at risk for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>